Salt Lake City, UT, May 29, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on May 26, 2026, the ...

The stock looks cheap, but appearances can be deceiving.

With an upside potential of 99.1% and a relative strength index (RSI) of 33.8, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...

A Harvard fellow and former financial intelligence chief argues the right model for AI governance isn't nuclear arms control ...

Uber COO Andrew Macdonald gave voice to the growing concerns that, despite spending big on AI, companies aren't seeing meaningful returns.

Formerly known as Verge Genomics, the new Verge Labs will help pharma and biotech partners match potential brain drugs to ...

Cognition makes Devin, the first and arguably most successful AI coding agent. But famed coder Wu says it isn't designed to supplant human programmers.

DeepSeek's permanent 75% price cut runs 87x cheaper on cache reads, pushing enterprise teams off Western APIs and threatening frontier lab revenue models.

According to the job description, the role involves reasoning about threats that may not yet exist but could emerge rapidly ...

OpenAI is reportedly preparing for a future where AI systems can improve themselves without human help. The company is now hiring safety researchers to study the risks tied to self-improving AI and ...